1. Effect of Danggui-Shaoyao-San-Containing Serum on the Renal Tubular Epithelial-Mesenchymal Transition of Diabetic Nephropathy
   Li Xiaobing et al, 2020, Current Pharmaceutical Biotechnology CrossRef
2. Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients
   Beata Kotowicz et al, 2017, PLOS ONE CrossRef
3. Collision carcinoma of endometrial adenocarcinoma and primary serous fallopian tube carcinoma: a case report
   Yun-Fei Pan et al, 2020, Journal of International Medical Research CrossRef
4. Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer in vitro under Cisplatin Treatment
   Przemysław Kieszkowski et al, 2020, Current Pharmaceutical Biotechnology CrossRef
5. Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer
   Marcin Opławski et al, 2017, Molecular Medicine Reports CrossRef
6. Cisplatin Changes Expression of SEMA3B in Endometrial Cancer
   Wojciech Peszek et al, 2020, Current Pharmaceutical Biotechnology CrossRef
7. Evaluation of Changes in the Expression Profile of mRNA and Proteinencoding Adiponectin in Ishikawa Cell Line under the Influence of Cisplatin – Preliminary Report
   Robert Kiełabsiński et al, 2020, Current Pharmaceutical Biotechnology CrossRef
8. Expression of NRP-1 and NRP-2 in Endometrial Cancer
   Marcin Oplawski et al, 2019, Current Pharmaceutical Biotechnology CrossRef
9. Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer
   Karol Talkowski et al, 2021, Current Pharmaceutical Biotechnology CrossRef